People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Other Health Care, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Phreesia, Inc. | — | Other Health Care | Series B | $83.8M | $753.2M | 2017 |
| Parcxmart Technologies, Inc. | — | Other Technology | Pre-Seed | $476K | $20.2M | 2009 |
Charles Kallenbach at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Charles Kallenbach on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Regan | 1 | 7 |
| Matthew Downs | 1 | 5 |
| William Conroy | 1 | 5 |
| Scott Perricelli | 1 | 4 |
| Victor Kats | 1 | 4 |
| Michael Weintraub | 1 | 3 |
| William J. Nyhan | 1 | 3 |
| Edward Cahill | 1 | 3 |
| Alan Spoon | 1 | 2 |
| Rory Parness | 1 | 2 |
| Bengt Karlsson | 1 | 2 |
| DUSTY LIEB | 1 | 2 |
| Chaim Indig | 1 | 1 |
| Evan Roberts | 1 | 1 |
| Thomas Altier | 1 | 1 |
| Thomas Feller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.